These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10160106)

  • 1. Do physicians' perceptions of drug costs influence their prescribing?
    Ryan M; Yule B; Bond C; Taylor RJ
    Pharmacoeconomics; 1996 Apr; 9(4):321-31. PubMed ID: 10160106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scottish general practitioners' attitudes and knowledge in respect of prescribing costs.
    Ryan M; Yule B; Bond C; Taylor RJ
    BMJ; 1990 May; 300(6735):1316-8. PubMed ID: 2369666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.
    Watkins C; Harvey I; Carthy P; Moore L; Robinson E; Brawn R
    Qual Saf Health Care; 2003 Feb; 12(1):29-34. PubMed ID: 12571342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of medicines in the United Kingdom. A survey of general practitioners' opinions and knowledge.
    Silcock J; Ryan M; Bond CM; Taylor RJ
    Pharmacoeconomics; 1997 Jan; 11(1):56-63. PubMed ID: 10165527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.
    Prosser H; Walley T
    Soc Sci Med; 2005 Mar; 60(6):1335-46. PubMed ID: 15626528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dutch GPs' perceptions: the influence of out-of-pocket costs on prescribing.
    Kasje WN; Timmer JW; Boendermaker PM; Haaijer-Ruskamp FM
    Soc Sci Med; 2002 Nov; 55(9):1571-8. PubMed ID: 12297243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NHS will publish national list of "low value" drugs to curb GPs' prescribing costs.
    Iacobucci G
    BMJ; 2017 Mar; 356():j1613. PubMed ID: 28360183
    [No Abstract]   [Full Text] [Related]  

  • 8. Physicians, pharmaceutical sales representatives, and the cost of prescribing.
    Caudill TS; Johnson MS; Rich EC; McKinney WP
    Arch Fam Med; 1996 Apr; 5(4):201-6. PubMed ID: 8769907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New medicines in primary care: a review of influences on general practitioner prescribing.
    Mason A
    J Clin Pharm Ther; 2008 Feb; 33(1):1-10. PubMed ID: 18211610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes and behaviour towards psychotropic drug prescribing in Swedish primary care: a questionnaire study.
    Svensson SA; Hedenrud TM; Wallerstedt SM
    BMC Fam Pract; 2019 Jan; 20(1):4. PubMed ID: 30611211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPs' perceptions of patient influence on prescribing.
    Stevenson FA; Greenfield SM; Jones M; Nayak A; Bradley CP
    Fam Pract; 1999 Jun; 16(3):255-61. PubMed ID: 10439979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication prescribing advice and drug utilization: a review from the United Kingdom.
    Law J; Thompson A
    Pharm Pract Manag Q; 1996 Jan; 15(4):27-35. PubMed ID: 10153842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary care physicians and the cost of drugs: a study of prescribing practices based on recognition and information sources.
    Walzak D; Swindells S; Bhardwaj A
    J Clin Pharmacol; 1994 Dec; 34(12):1159-63. PubMed ID: 7738210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drug uptake: qualitative comparison of high and low prescribing GPs' attitudes and approach.
    Prosser H; Walley T
    Fam Pract; 2003 Oct; 20(5):583-91. PubMed ID: 14507803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPs' attitudes to benzodiazepine and 'Z-drug' prescribing: a barrier to implementation of evidence and guidance on hypnotics.
    Siriwardena AN; Qureshi Z; Gibson S; Collier S; Latham M
    Br J Gen Pract; 2006 Dec; 56(533):964-7. PubMed ID: 17132386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of factors associated with cost and variation in prescribing among GPs.
    Carthy P; Harvey I; Brawn R; Watkins C
    Fam Pract; 2000 Feb; 17(1):36-41. PubMed ID: 10673486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pressures on the general practitioner and decisions to prescribe.
    Weiss MC; Fitzpatrick R; Scott DK; Goldacre MJ
    Fam Pract; 1996 Oct; 13(5):432-8. PubMed ID: 8902511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does knowledge of medication prices predict physicians' support for cost effective prescribing policies.
    Polinski JM; Maclure M; Marshall B; Cassels A; Agnew-Blais J; Patrick AR; Schneeweiss S
    Can J Clin Pharmacol; 2008; 15(2):e286-94. PubMed ID: 18641423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health information technology and physicians' knowledge of drug costs.
    Tseng CW; Brook RH; Alexander GC; Hixon AL; Keeler EB; Mangione CM; Chen R; Jackson EA; Dudley RA
    Am J Manag Care; 2010 Apr; 16(4):e105-10. PubMed ID: 20370310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.